Johnson & Johnson News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

19.04.22	Johnson & Johnson Suspends Guidance On Its COVID-19 Vaccine Sales (RTTNews)
19.04.22	Johnson & Johnson Q1 Profit Decreases, but beats estimates (RTTNews)
19.04.22	Johnson & Johnson Reports Q1 2022 Results (PR Newswire)
19.04.22	Johnson & Johnson Announces Dividend Increase of 6.6% (PR Newswire)
13.04.22	J&J Ordered To Pay $302 Mln Penalty For Wrong Pelvic Mesh Implant Ads (RTTNews)
07.04.22	Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference (PR Newswire)
25.03.22	ViiV Healthcare : FDA Approves Label Update For Long-acting HIV Treatment Cabenuva (RTTNews)
15.03.22	Johnson & Johnson to Host Investor Conference Call on First-Quarter Results (PR Newswire)
09.03.22	Form 4 200406 (RSS)
01.03.22	Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease (PR Newswire)
25.02.22	J&J Bankruptcy Ploy Upheld By NJ Court (RTTNews)
25.02.22	Initial statement of beneficial ownership of securities (RSS)
15.02.22	Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors (PR Newswire)
15.02.22	Form 4 200406 (RSS)
09.02.22	Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference (PR Newswire)
08.02.22	J&J Stops Production Of Its COVID-19 Vaccine, Says NYT (RTTNews)
07.02.22	Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference (PR Newswire)
27.01.22	Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference (PR Newswire)
25.01.22	Johnson & Johnson Projects 2022 Adj. Operational EPS Growth Of 9.2% (RTTNews)
25.01.22	Johnson & Johnson Q4 Profit Increases, beats estimates (RTTNews)
25.01.22	Johnson & Johnson Reports Q4 and Full-Year 2021 Results (PR Newswire)
19.01.22	Form 4 200406 (RSS)
13.01.22	Initial statement of beneficial ownership of securities (RSS)
07.01.22	Johnson & Johnson Vaccine Protects Up To Six Months Against COVID-19 Breakthrough Infections (RTTNews)
06.01.22	Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States (PR Newswire)
04.01.22	Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022 (PR Newswire)
30.12.21	J&J's COVID-19 Booster Shot 85% Effective Against Hospitalization, In South Africa Phase 3 Study (RTTNews)
30.12.21	Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant (PR Newswire)
23.12.21	Top 10 Blockbuster Drugs In 2021 (RTTNews)
17.12.21	CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots (RTTNews)
15.12.21	Johnson & Johnson Receives Positive CHMP Opinion For Booster Shot Of COVID-19 Vaccine (RTTNews)
15.12.21	Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine (PR Newswire)
15.12.21	EMA Recommends Covid-19 Vaccine Janssen Booster Shot For Adults (RTTNews)
13.12.21	J&J Talcum Powder Woes Continue As SC Declines To Hear The Company (RTTNews)
10.12.21	Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results (PR Newswire)
09.12.21	World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster (PR Newswire)
09.12.21	Johnson & Johnson Appoints Senior Leaders to Executive Committee (PR Newswire)
06.12.21	Johnson & Johnson Says Its COVID-19 Booster Shows Increase In Antibody And T-cell Responses (RTTNews)
05.12.21	Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses (PR Newswire)
04.12.21	Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine Candidate at ESWI 2021 (PR Newswire)
02.12.21	Amgen : FDA Approves Kyprolis Combination Regimen For Multiple Myeloma Treatment (RTTNews)
30.11.21	CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns (RTTNews)
29.11.21	Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed (RTTNews)
24.11.21	Health Canada Approves Johnson & Johnson COVID-19 Vaccine - Quick Facts (RTTNews)
12.11.21	J&J Plans To Form Separate Consumer Health Company (RTTNews)
12.11.21	Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business (PR Newswire)
10.11.21	Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer (PR Newswire)
09.11.21	Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards (PR Newswire)
22.10.21	Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots In U.S. (RTTNews)
22.10.21	CDC Panel Backs Johnson & Johnson COVID-19 Booster Shot (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

16:53		BioNTech zahlt Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester
16:01		Verluste in New York: Dow Jones präsentiert sich zum Start leichter
16:01		Verluste in New York: S&P 500 legt zum Start des Freitagshandels den Rückwärtsgang ein
15:58		Handel in Frankfurt: LUS-DAX am Freitagnachmittag mit grünem Vorzeichen
15:58		Gewinne in Zürich: SPI am Nachmittag freundlich
15:58		Freundlicher Handel: Euro STOXX 50 nachmittags mit positivem Vorzeichen

16:53

BioNTech zahlt Milliardenbetrag für Impfstoffvergleich in USA - BioNTech-Aktie fester

16:01

Verluste in New York: Dow Jones präsentiert sich zum Start leichter

16:01

Verluste in New York: S&P 500 legt zum Start des Freitagshandels den Rückwärtsgang ein

15:58

Handel in Frankfurt: LUS-DAX am Freitagnachmittag mit grünem Vorzeichen

15:58

Gewinne in Zürich: SPI am Nachmittag freundlich

15:58

Freundlicher Handel: Euro STOXX 50 nachmittags mit positivem Vorzeichen

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.69	2.29 %	K V
Kuehne+Nagel Int	207.80	1.37 %	K V
Logitech Intl	75.16	1.16 %	K V
Part Grp Hldg	1’232.00	1.15 %	K V
Novartis	88.68	1.14 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.40	0.27 %	K V
Swiss Life Hldg	698.20	0.23 %	K V
Holcim	87.38	0.00 %	K V
Zurich Insur Gr	538.20	-0.15 %	K V

Nachrichten zu Johnson & Johnson

Aktien Top/Flop

Johnson & Johnson Peer Group Nachrichten

Meistgelesene Nachrichten